Development Of A Box–Behnken Design Optimized Linagliptin Liposphere Formulation For Improved Bioavailability And Sustained Release. JOC [Internet]. 2025 Sep. 30 [cited 2025 Dec. 8];24(7s):866-77. Available from: https://carcinogenesis.com/index.php/JOC/article/view/1187